Despite the crucial roles played by the ILK and PI3K/AKT signaling pathways in cardiac survival, growth, function, and repair, attenuation of DCM by liraglutide via the ILK and PI3K/Akt/PTEN axis has not been confirmed. The gene discussed is PTEN; the disease is familial dilated cardiomyopathy.